Self-Injection Market, By Type (Needle Free Injectors (NFI), Auto Injectors, Pen Injectors, Wearable Injectors), Application (Oncology, Hormonal Disorders, Autoimmune diseases, Orphan Disease, Other Applications), Pattern (Immunizations, Curative Care, Others), Mode of Administration(Skin, Circulatory/ Muskoskeletal, Organs, Central Nervous System), End User(Hospitals and Clinics, Home Healthcare Settings, Research Laboratories, Pharmaceutical And Biotechnological Companies, Other End User), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global self-injection market is anticipated to reach USD 9.1 billion by 2020 growing at a CAGR of 11.8% during the forecasting period, 2020-2028. Self-injection is an emerging option for administering drug therapies at home like insulin-dependent diabetics generally adopt self-inject medication as it is an easy and reliable method to self-administer drugs. Factors such as the high prevalence and incidence rate of chronic diseases and the growth of the biologics market are some of the major drivers for the self-injection market
The global self-injection market is segmented into areas, cancer type, treatment, technology, drugs, stage, end-user, and geography.
Areas segment is segmented into Medical, Surgical, and Radiation. Medical is further segmented into Chemotherapy, Targeted Therapy, and Immunotherapy. Surgical is further segmented into Image-Guided Biopsy, Fine Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Excisional Biopsy, Shave Biopsy, Punch Biopsy, Endoscopic Biopsy, Laparoscopic Biopsy, Bone Marrow Aspiration and Biopsy and Liquid Biopsy.
The cancer type segment is segmented into Haematology Cancer, Ovarian Cancer, Pancreatic Cancer, Lung Cancer, Bladder Cancer, Prostate Cancer, Breast Cancer, Kidney Cancer, and Others
Treatment segment is segmented into Combination Therapy, Adjuvant Therapy, Supportive Therapy, Palliative Care and Others
The technology segment is segmented into Car-T Cell Therapy, CRISPR/CAS9, and Others
Drugs segment is segmented into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi, and Others
Stage segment is segmented into Stage I, Stage II, Stage III, and Stage IV
The end-users segment is segmented into Hospitals, Specialty Clinics, Self-injection Centers, Surgical Centers, and Others.
Geographically, the global self-injection market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
North America region is the largest contributor to the self-injection market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.
Key players in the global self-injection market are Elcam Medical, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Inc, Pfizer Inc., Impax Laboratories, Inc., Penjet Corporation, Crossject Needle-Free Injection Systems, Terumo Corporation, Antares Pharma, Becton, Dickinson And Company, Gerresheimer AG, Mylan N.V, Novo Nordisk, Owen Mumford Ltd, Pharmajet, SHL Group, Ypsomed Wilhelm Haselmeier Gmbh & CO. KG, Wilhelm Haselmeier Gmbh & CO. KG and among others among others
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
Hence, tremendous progress has been made over the last decade and yet a lot more to come in recent years.
Report Features |
Description |
---|---|
Market Revenue In 2020 |
USD 9.1 billion |
Growth Rate |
CAGR of 11.8% during the forecasting period, 2020-2028 |
Historical Data |
2017-2018 |
Forecast Years |
2020-2028 |
Base Year |
2019 |
Units Considered |
Revenue in USD billion and CAGR from 2020 to 2028 |
Report Segmentation |
Areas, Cancer Type, Treatment, Technology, Drugs, Stage, End-User, and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Elcam Medical, Bespak, Sanofi, Sandoz International Gmbh, Unilife Corporation, West Pharmaceutical Services, Inc, Pfizer Inc., Impax Laboratories, Inc., Penjet Corporation, Crossject Needle-Free Injection Systems, Terumo Corporation, Antares Pharma, Becton, Dickinson And Company, Gerresheimer AG, Mylan N.V, Novo Nordisk, Owen Mumford Ltd, Pharmajet, SHL Group, Ypsomed Wilhelm Haselmeier Gmbh & CO. KG, Wilhelm Haselmeier Gmbh & CO. KG and among others among others |
Available Customization |
In addition to the market data for the self-injection market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements. |